These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 37400870)

  • 1. Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease.
    Yu SP; Jiang MQ; Shim SS; Pourkhodadad S; Wei L
    Mol Neurodegener; 2023 Jul; 18(1):43. PubMed ID: 37400870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.
    Zhong W; Wu A; Berglund K; Gu X; Jiang MQ; Talati J; Zhao J; Wei L; Yu SP
    Alzheimers Dement; 2022 Feb; 18(2):222-239. PubMed ID: 34151525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
    Lipton SA
    Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Glutamate and NMDA Receptors in Alzheimer's Disease.
    Wang R; Reddy PH
    J Alzheimers Dis; 2017; 57(4):1041-1048. PubMed ID: 27662322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.
    Folch J; Busquets O; Ettcheto M; Sánchez-López E; Castro-Torres RD; Verdaguer E; Garcia ML; Olloquequi J; Casadesús G; Beas-Zarate C; Pelegri C; Vilaplana J; Auladell C; Camins A
    J Alzheimers Dis; 2018; 62(3):1223-1240. PubMed ID: 29254093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
    Vizi ES; Kisfali M; Lőrincz T
    Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury.
    Zong P; Feng J; Yue Z; Li Y; Wu G; Sun B; He Y; Miller B; Yu AS; Su Z; Xie J; Mori Y; Hao B; Yue L
    Neuron; 2022 Jun; 110(12):1944-1958.e8. PubMed ID: 35421327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
    Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
    J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.
    Olivares D; Deshpande VK; Shi Y; Lahiri DK; Greig NH; Rogers JT; Huang X
    Curr Alzheimer Res; 2012 Jul; 9(6):746-58. PubMed ID: 21875407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses.
    Xia P; Chen HS; Zhang D; Lipton SA
    J Neurosci; 2010 Aug; 30(33):11246-50. PubMed ID: 20720132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral.
    Rush T; Buisson A
    Cell Tissue Res; 2014 May; 356(2):279-86. PubMed ID: 24496511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity.
    Olajide OJ; Gbadamosi IT; Yawson EO; Arogundade T; Lewu FS; Ogunrinola KY; Adigun OO; Bamisi O; Lambe E; Arietarhire LO; Oluyomi OO; Idowu OK; Kareem R; Asogwa NT; Adeniyi PA
    J Mol Neurosci; 2021 Jun; 71(6):1205-1220. PubMed ID: 33420680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β.
    Wang ZC; Zhao J; Li S
    Neurosci Bull; 2013 Dec; 29(6):752-60. PubMed ID: 24136243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
    Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.